|
1
|
de Bono JS and Rowinsky EK: The ErbB
receptor family: a therapeutic target for cancer. Trends Mol Med.
8(Suppl 4): S19–S26. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mendelsohn J and Baselga J: The EGF
receptor family as targets for cancer therapy. Oncogene.
19:6550–6565. 2000. View Article : Google Scholar
|
|
3
|
Carpenter G and Cohen S: Epidermal growth
factor. J Biol Chem. 265:7709–7712. 1990.PubMed/NCBI
|
|
4
|
Yarden Y: The EGFR family and its ligands
in human cancer. Signaling mechanisms and therapeutic
opportunities. Eur J Cancer. 37(Suppl 4): S3–S8. 2001. View Article : Google Scholar
|
|
5
|
Ullrich A and Schlessinger J: Signal
transduction by receptors with tyrosine kinase activity. Cell.
61:203–212. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schlessinger J: Common and distinct
elements in cellular signaling via EGF and FGF receptors. Science.
306:1506–1507. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Engelman JA and Cantley LC: The role of
the ErbB family members in non-small cell lung cancers sensitive to
epidermal growth factor receptor kinase inhibitors. Clin Cancer
Res. 12:4372s–4376s. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Henne WM, Buchkovich NJ and Emr SD: The
ESCRT pathway. Dev Cell. 21:77–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arteaga CL and Johnson DH: Tyrosine kinase
inhibitors-ZD1839 (Iressa). Curr Opin Oncol. 13:491–498. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barker AJ, Gibson KH, Grundy W, Godfrey
AA, Barlow JJ, Healy MP, Woodburn JR, Ashton SE, Curry BJ, Scarlett
L, Henthorn L and Richards L: Studies leading to the identification
of ZD1839 (IRESSA): an orally active, selective epidermal growth
factor receptor tyrosine kinase inhibitor targeted to the treatment
of cancer. Bioorg Med Chem Lett. 11:1911–1914. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baselga J and Averbuch SD: ZD1839
(‘Iressa’) as an anticancer agent. Drugs. 60(Suppl 1): S33–S42.
2000. View Article : Google Scholar
|
|
12
|
Woodburn JR: The epidermal growth factor
receptor and its inhibition in cancer therapy. Pharmacol Ther.
82:241–250. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lynch TJ, Bell DW, Sordella R,
Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat
SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J and
Haber DA: Activating mutations in the epidermal growth factor
receptor underlying responsiveness of non-small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paez JG, Jänne PA, Lee JC, Tracy S,
Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ,
Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE and
Meyerson M: EGFR mutations in lung cancer: correlation with
clinical response to gefitinib therapy. Science. 304:1497–1500.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Engelman JA, Zejnullahu K, Mitsudomi T,
Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen
J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C,
Johnson BE, Cantley LC and Jänne PA: MET amplification leads to
gefitinib resistance in lung cancer by activating ERBB3 signaling.
Science. 316:1039–1043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishimura Y, Bereczky B and Ono M: The
EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis
of EGFR via the early/late endocytic pathway in non-small cell lung
cancer cell lines. Histochem Cell Biol. 127:541–553. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishimura Y, Yoshioka K, Bereczky B and
Itoh K: Evidence for efficient phosphorylation of EGFR and rapid
endocytosis of phosphorylated EGFR via the early/late endocytic
pathway in a gefitinib-sensitive non-small cell lung cancer cell
line. Mol Cancer. 7:422008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nishimura Y, Yoshioka K, Takiguchi S,
Bereczky B, Nakabeppu Y and Itoh K: A role for SNX1 in the
regulation of EGF-dependent phosphorylated EGFR endocytosis via the
early/late endocytic pathway in a gefitinib-sensitive human lung
cancer cells. Curr Signal Transduct Ther. 6:383–395. 2011.
View Article : Google Scholar
|
|
19
|
Nishimura Y, Takiguchi S, Yoshioka K,
Nakabeppu Y and Itoh K: Silencing of SNX1 by siRNA stimulates the
ligand-induced endocytosis of EGFR and increases EGFR
phosphorylation in gefitinib-resistant human lung cancer cell
lines. Int J Oncol. 41:1520–1530. 2012.PubMed/NCBI
|
|
20
|
Nishimura Y, Takiguchi S, Ito S and Itoh
K: Evidence that depletion of the sorting nexin 1 by siRNA promotes
HGF-induced MET endocytosis and MET phosphorylation in a
gefitinib-resistant human lung cancer cell line. Int J Oncol.
44:412–426. 2014.
|
|
21
|
Kurten RC, Cadena DL and Gill GN: Enhanced
degradation of EGF receptors by a sorting nexin, SNX1. Science.
272:1008–1010. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Worby CA and Dixon JE: Sorting out the
cellular function of sorting nexins. Nat Rev Mol Cell Biol.
3:919–931. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong Q, Lasar CS, Tronchère H, Sato T,
Meerloo T, Yeo M, Songyang Z, Emr SD and Gill GN: Endosomal
localization and function of sorting nexin 1. Proc Natl Acad Sci
USA. 99:6767–6772. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carlton J, Bujny M, Peter BJ, Oorschot VM,
Rutherford A, Mellor H, Klumperman J, McMahon HT and Cullen PJ:
Sorting nexin-1 mediates tubular endosome-to-TGN transport through
coincidence sensing of high-curvature membranes and
3-phosphoinositides. Curr Biol. 14:1791–1800. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gullapalli A, Garrett TA, Paing MM,
Griffin CT, Yang Y and Trejo J: A role for sorting nexin 2 in
epidermal growth factor receptor down-regulation: evidence for
distinct functions of sorting nexin 1 and 2 in protein trafficking.
Mol Biol Cell. 15:2143–2155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nishimura Y, Higaki M and Kato K:
Identification of a precursor form of cathepsin D in microsomal
lumen: characterization of enzymatic activation and proteolytic
processing in vitro. Biochem Biophys Res Commun. 148:335–343. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nishimura Y, Kawabata T and Kato K:
Identification of latent procathepsins B and L in microsomal lumen:
characterization of enzymatic activation and proteolytic processing
in vitro. Arch Biochem Biophys. 261:64–71. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kornfeld S and Mellman I: The biogenesis
of lysosomes. Ann Rev Cell Biol. 5:483–525. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sandoval IV, Arredondo JJ, Alcalde J,
Gonzalez-Noriega A, Vandekerckhove J, Jimenez MA and Rico M: The
residues Leu(Ile)475-Ile(Leu, Val, Ala)476, contained in the
extended carboxyl cytoplasmic tail, are critical for targeting of
the resident lysosomal membrane protein LIMP II to lysosomes. J
Biol Chem. 269:6622–6631. 1994.PubMed/NCBI
|
|
30
|
Jones MC, Caswell PT and Norman JC:
Endocytic recycling pathways: emerging regulators of cell
migration. Curr Opin Cell Biol. 18:549–557. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Felder S, Miller K, Moehren G, Ullrich A,
Schlessinger J and Hopkins CR: Kinase activity controls the sorting
of the epidermal growth factor receptor within the multivesicular
body. Cell. 61:623–634. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ullrich O, Reinsch S, Urbé S, Zerial M and
Parton RG: Rab11 regulates recycling through the pericentriolar
recycling endosome. J Cell Biol. 135:913–924. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alessi DR, James SR, Downes CP, Holmes AB,
Gaffney PR, Reese CB and Cohen P: Characterization of a
3-phosphoinositide-dependent protein kinase which phosphorylates
and activates protein kinase Bα. Curr Biol. 7:261–269. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jacinto E, Facchinetti V, Liu D, Soto N,
Wei S, Jung SY, Huang Q, Qin J and Su B: SIN1/MIP1 maintains
rictor-mTOR complex integrity and regulates Akt phosphorylation and
substrate specificity. Cell. 127:125–137. 2006. View Article : Google Scholar : PubMed/NCBI
|
